Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Shares Outstanding (Diluted Average) (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Shares Outstanding (Diluted Average) readings, the most recent being $63.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 1.86% to $63.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $63.3 million, a 1.86% increase, with the full-year FY2025 number at $63.3 million, up 1.86% from a year prior.
  • Shares Outstanding (Diluted Average) hit $63.3 million in Q4 2025 for Treace Medical Concepts, roughly flat from $63.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $63.3 million in Q4 2025 to a low of $43.6 million in Q2 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $60.9 million (2023), compared with a mean of $58.3 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 30.61% in 2021 and later increased 0.9% in 2024.
  • Treace Medical Concepts' Shares Outstanding (Diluted Average) stood at $48.4 million in 2021, then rose by 14.17% to $55.3 million in 2022, then grew by 10.09% to $60.9 million in 2023, then rose by 2.07% to $62.1 million in 2024, then grew by 1.86% to $63.3 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $63.3 million (Q4 2025), $63.1 million (Q3 2025), and $63.0 million (Q2 2025) per Business Quant data.